USPTO serial 99542508
TRELYSRWD
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- OPUTA, CHIOMA N
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with TRELYSRWD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anuj Desai
Anuj Desai Arnall Golden Gregory LLP171 17th St NWSuite 2100Atlanta, GA 30363Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business data research; Analysis of market research data and statistics; Consultation services in the field of company, business sector and industry data and research; Analyzing and compiling business data; Consultancy and advisory services in the field of business strategy; Market research consultation; Marketing research services in the nature of tracking consumer behavior and analyzing consumer trends; Collection and analysis of healthcare quality data for business purposes; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Collecting and analyzing claims data from healthcare organizations for business purposes; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Assistance in management of business activities; Business consulting and management in the field of clinical trials, namely, providing information management services; Compiling and analyzing statistics, data and other sources of information for business purposes; Statistical analysis and reporting services for business purposes; Preparing business reports; Business strategy development services; Consumer strategy business consulting in the fields of marketing, sales, operation, and product design particularly specializing in the use of analytic models for the understanding and predicting of consumer, business, and retail market trends and actions; Development of marketing strategies and concepts; Outsource service provider in the field of business analytics; Market analysis; Business data analysis; Analysis of business data; Market analysis and research services; Preparation of market analysis reports; Business advice and analysis of markets; Assistance, advisory services and consultancy with regard to business analysis; Outsource service provider in the field of business management of collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Outsource service provider in the field of business management of collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Outsource service provider in the field of business management of data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Analyzing and compiling business data for the pharmaceutical, medical, healthcare and life sciences fields; Business assistance, advisory and consulting services in the field of collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Business assistance, advisory and consulting services in the field of collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Business data analysis services in the field of the pharmaceutical, medical, healthcare and life sciences fields; Business management in the field of collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Business management in the field of collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Business research and data analysis services in the field of collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Business research and data analysis services in the field of collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Collection and analysis of quality metric data for the pharmaceutical, medical, healthcare and life sciences fields for business purposes; Business assistance, advisory and consulting services in the field of data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Business management in the field of data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information | ACTIVE | — |
| 042 | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the field of clinical trials; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for data exploration; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for data assessment; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for data analytics; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for creating complex data science analyses; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for business analytics; Artificial intelligence as a service (AIAAS) featuring software using artificial intelligence for analyzing data and interacting with humans; Artificial intelligence as a service (AIAAS) featuring software using artificial intelligence for writing custom algorithms and implementing algorithms into dataflows; Design and development of artificial intelligence (AI) software on an outsourcing basis; Software as a service (SAAS) services featuring artificial intelligence (AI) software for generating business analysis reports; Consulting services for others in the field of design, planning, and implementation project management of collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Scientific research consulting services for others in the field of design, planning, and implementation project management of collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Scientific research consulting services for others in the field of design, planning, and implementation project management of data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Consulting services for others in the use of technology in the field of design, planning, and implementation project management of collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Consulting services for others in the use of technology in the field of design, planning, and implementation project management of data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Providing on-line non-downloadable software using artificial intelligence (AI) for collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Providing on-line non-downloadable software using artificial intelligence (AI) for collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Providing on-line non-downloadable software using artificial intelligence (AI) for data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Providing online non-downloadable software using machine learning for collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Providing online non-downloadable software using machine learning for collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Providing online non-downloadable software using machine learning for data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Providing temporary use of on-line non-downloadable cloud computing software for collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Providing temporary use of on-line non-downloadable cloud computing software for collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Providing temporary use of on-line non-downloadable cloud computing software for data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Software as a service (SAAS) services featuring software for collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Software as a service (SAAS) services featuring software for collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Software as a service (SAAS) services featuring software for data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Assembled Intelligence LLC
- Other trademarks owned by Assembled Intelligence LLC
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named TRELYSRWD
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 2, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 2, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 6, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 6, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 6, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 6, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 15, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 11, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 11, 2025 | NWAP | NEW APPLICATION ENTERED | — |